Development & Aid, Headlines, Health, North America

HEALTH-U.S.: Stem Cell Research Could Exclude Groups – Scientists

Katherine Stapp

NEW YORK, Aug 23 2002 (IPS) - Much U.S.-funded stem cell research could prove useful only for a narrow segment of the population because the samples lack genetic diversity, say many scientists and public health advocates.

Compromise rules announced by U.S. President George Bush a year ago permit government-funded research only on existing stem cell lines using embryos that have already been destroyed. The decision excluded thousands of unwanted eggs in fertility clinics ¡ the main source of embryonic stem cells.

At the time of the announcement last Aug. 9, only 64 lines of cells in the world qualified for federal funding. As of this month, according to the National Institutes of Health registry, the number is 78, but reporters and scientists say that only between 10 and 20 cell lines are currently viable for research.

The cells are sitting in 14 labs in the United States, Australia, Sweden, South Korea, India and Israel.

Each cell line comes from two people, so the NIH-funded research is focusing on 20 to 40 individuals.

The small sample troubles many experts in the field.

Late last year, U.S. journalist Jon Entine and Sally Satel, a fellow at the conservative American Enterprise Institute, called up the 10 labs that had been green-lighted by the federal government. They found that of the 64 stem cell lines initially approved by the Bush administration, 49 came from white couples. The remaining 15 came from East Asian donors, they said.

Humans share most of their 40,000 genes, but small differences arise, mostly due to geography. It is not simply a “black” and “white” issue, Entine and Satel said.

“It is well-documented that populations in Africa, where modern humans likely originated, are the most genetically diverse in the world,” they wrote in a Washington Post article titled ‘Race Belongs in the Stem Cell Debate’.

“A stem cell policy that does not guarantee a significant percentage of cell lines from various African sub-populations will limit human biodiversity – and could limit the effectiveness of drug therapies on those and other populations not adequately represented in the current cell lines.”

African American health advocates are also concerned about the lack of sample diversity.

“The president’s decision to restrict embryonic stem cell research is an unfortunate step backward for the health of future generations and the ultimate elimination of racial health disparities,” said Lorraine Cole, president of the National Black Women’s Health Project in Washington, D.C.

“Embryonic stem cell research has great potential to turn the tide on a variety of diseases and health conditions that disproportionately affect African Americans, like diabetes, Alzheimer’s disease, Parkinson’s disease, cancers, spinal cord injuries and many others,” she said.

“It is highly questionable if the limited number of existing stem cell lines available for federally supported research could mirror the genetic diversity of this nation, much less the world.”

The Bush rules only apply to researchers seeking federal funding. But Kevin Wilson, director of public policy at the American Society for Cell Biology in Maryland, pointed out that the amount spent by private labs to develop their own cell lines pales in comparison to the millions of dollars awarded by the National Institutes of Health. And the NIH is giving grants only for a handful of cell lines.

“The NIH policy is basically, walk before you run,” Wilson said. “There’s nothing wrong with that. The problem is that, from a research point of view, we need to know there’s a commitment to go beyond what we know now. The Bush administration is saying ‘this is all you get’.”

“The policy is written in stone ¡ with the potential of changing,” he said wryly. “Once some important scientific discoveries are made, public pressure may be brought to bear to expand the research.”

Embryonic stem cell research has been a hot-button issue since 1998, when a biologist at the University of Wisconsin isolated the cells in a lab.

Stem cells can be derived from adult bone marrow, and from human embryos that are just a few days old. They hold great promise for repairing tissue damage from disease or injury because researchers have figured out how to turn them into any type of specialised cell in the human body.

The process entails stripping the nucleus from a host stem cell and replacing it with the nucleus of a heart or nerve cell, for example. Once the cell begins dividing, stem cells can be extracted about a week later. In theory, the cells can keep dividing indefinitely, creating a stem cell line.

Embryonic stem cell research lies at the heart of the ethical controversy. Opponents ¡ many from the anti-abortion movement – argue that fertilised eggs are human beings. In their view, the destruction of embryos for research is immoral.

They say that adult stem cells are a perfectly acceptable research alternative, although most scientists disagree with this claim.

The current U.S. rules represent a middle ground between groups lobbying to ban embryonic research entirely and scientists seeking free use of unwanted eggs.

Religious objections aside, others – a minority – oppose the research because they believe the money would be better spent addressing basic health care inequities.

“The problem is how custom-made this is,” says Abby Lippman, a professor of epidemiology at McGill University in Montreal. “It only benefits an elite segment of the population.”

“The bulk of the world’s population lacks even basic health care. Poverty and violence are still the main problems,” she said, adding stem cell research “is just one more way of making money for the biotech companies”.

Since the research is in its infancy, even proponents are wary of speculating about when the public will see benefits.

“We may find out in the long run that embryonic cells are good for some things, and adult stem cells are good for other things,” said Kevin Wilson. “We just don’t know yet.”

 
Republish | | Print |

Related Tags